Concepedia

Eiji Torikai

ET

Statistics

Publications

16

Citations

524

H-Index

14

Active since

2006

Affiliations

Hamamatsu University School of Medicine(Current)

Hamamatsu University

Eiji Torikai is an author at Hamamatsu University School of Medicine specializing in rheumatoid arthritis, medicine, and rheumatology.

Top concepts

Publications per year

2006–2012

16

Publications

16

Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis.

Yasunori Kageyama, M Takahashi, Tetsuya Ichikawa et al. · PubMed · 2008 · 74 citations

, , +23

Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis

Yasunori Kageyama, Masaaki Takahashi, Tetsuyuki Nagafusa et al. · Rheumatology International · 2007 · 69 citations

, , +12

Etanercept reduces the serum levels of interleukin-23 and macrophage inflammatory protein-3 alpha in patients with rheumatoid arthritis

Yasunori Kageyama, Tetsuya Ichikawa, Tetsuyuki Nagafusa et al. · Rheumatology International · 2007 · 67 citations

, , +11

Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33

Yasunori Kageyama, Eiji Torikai, Kunio Tsujimura et al. · Modern Rheumatology · 2011 · 40 citations

, , +14

Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis

Yasunori Kageyama, Eiji Torikai, Akira Nagano · Rheumatology International · 2006 · 36 citations

, , +12

Rows per page

1–5 of 16